Why Should U.S. Companies Consider Public Venture Capital?
The MedCity INVEST conference included a panel discussion on raising public venture capital in Canada, sponsored by Cozen O’Connor and TSX.
How do health IT investment trends in China and U.S. differ?
Health IT investment in the U.S. and China was hot in Q2, but what are some of the areas where these two markets differ?
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
The FDA wants more medical device companies to get on board with the international audit program
Not many medical device companies are stepping up to participate in the international Medical Device Single Audit Program, which has the FDA peeved.